http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016124861-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_650add86168b1a60eb53f021958927c2
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2015-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c5e925e17bc3d149fba066e0e528bee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5b7fa9db5b49ab5d7994a3666a9ee44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb74cf9e16f3d4560d0330541dccf99c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6750597bf803396d7e14995b82ba092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_784778b8dd1fa404bcb04e1d00857d81
publicationDate 2016-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2016124861-A
titleOfInvention Ormesartan medoxomil-containing orally disintegrating tablets
abstract An orally disintegrating tablet containing olmesartan medoxomil that suppresses bitterness by a simple production process is provided. According to one embodiment of the present invention, there is provided an ormesartan medoxomil-containing orally disintegrating tablet characterized by containing olmesartan medoxomil and more than 10 mg and 35 mg or less of carmellose. According to one embodiment of the present invention, the acidic bitter taste of olmesartan medoxomil can be suppressed by adding carmellose. [Selection] Figure 1
priorityDate 2014-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449282311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71431045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423352616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451138626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411174056
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154825534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415822791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448612174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10415276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51064083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453635562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45266664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415828206
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID183

Total number of triples: 44.